Centre for Drug Research and Development:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Centre for Drug Research and Development - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C9384
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:29
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:カナダ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Centre for Drug Research and Development (CDRD) is a drug development and commercialization center that provides scientific infrastructure to transform discoveries into innovative therapeutic products and improved health outcomes. The center’s drug development platform includes target validation, screening, drug delivery, medicinal chemistry, pharmacology and toxicology, biologics and external platforms. It spans its expertise in the therapeutic areas of neuroscience, oncology, inflammation, fibrosis and other indications. CDRD’s target validation programs comprise vivo efficacy model development, assay development and transfer, and others. The center has also established national, provincial, and international partnerships, and developed specially-trained highly-qualified personnel. CDRD is headquartered in Vancouver, British Columbia, Canada.

Centre for Drug Research and Development – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Centre for Drug Research and Development, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Centre for Drug Research and Development, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Centre for Drug Research and Development, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Centre for Drug Research and Development, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Centre for Drug Research and Development, Medical Devices Deals, 2012 to YTD 2018 9
Centre for Drug Research and Development, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Centre for Drug Research and Development, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
Zucara Therapeutics Raises USD0.4 Million in Venture Financing 11
Partnerships 13
Schrodinger Enters into Partnership with Centre for Drug Research and Development 13
Aequus Pharma and Centre for Drug Research and Development Enter into a Research Agreement 14
Novelogics Biotech Enters into Research Agreement with Centre for Drug Research and Development 15
Centre for Drug Research and Development Partners with AstraZeneca 16
Centre for Drug Research and Development Enters into Agreement with viDA Therapeutics 17
Centre for Drug Research and Development and Centre Hospitalier Universitaire de Sherbrooke Enter into Development Partnership 18
Licensing Agreements 19
Zucara Therapeutics Enters into Licensing Agreement with Centre for Drug Research and Development 19
Centre for Drug Research and Development – Key Employees 20
Centre for Drug Research and Development – Locations And Subsidiaries 21
Head Office 21
Recent Developments 22
Corporate Communications 22
Oct 15, 2018: CDRD appoints Didier Leconte to Its Board of Directors 22
Oct 11, 2017: CDRD Announces Appointments to its Board of Directors 23
May 01, 2017: CDRD appoints CFO 24
May 01, 2017: CDRD Appoints Matthew J. Carlyle Chief Financial Officer 25
Feb 01, 2017: CDRD Appoints Gordon McCauley as President and CEO 26
Government and Public Interest 27
Mar 09, 2017: Stem Cell & Regenerative Medicine Leaders Join Forces to Advance Canada’s Position in the Field 27
Product News 28
Jun 27, 2017: LifeArc, Dstl and CDRD Collaborate to Identify Antibacterial Drug Targets 28
Appendix 29
Methodology 29
About GlobalData 29
Contact Us 29
Disclaimer 29

List of Tables
Centre for Drug Research and Development, Pharmaceuticals & Healthcare, Key Facts 2
Centre for Drug Research and Development, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Centre for Drug Research and Development, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Centre for Drug Research and Development, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Centre for Drug Research and Development, Deals By Therapy Area, 2012 to YTD 2018 8
Centre for Drug Research and Development, Medical Devices Deals, 2012 to YTD 2018 9
Centre for Drug Research and Development, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Zucara Therapeutics Raises USD0.4 Million in Venture Financing 11
Schrodinger Enters into Partnership with Centre for Drug Research and Development 13
Aequus Pharma and Centre for Drug Research and Development Enter into a Research Agreement 14
Novelogics Biotech Enters into Research Agreement with Centre for Drug Research and Development 15
Centre for Drug Research and Development Partners with AstraZeneca 16
Centre for Drug Research and Development Enters into Agreement with viDA Therapeutics 17
Centre for Drug Research and Development and Centre Hospitalier Universitaire de Sherbrooke Enter into Development Partnership 18
Zucara Therapeutics Enters into Licensing Agreement with Centre for Drug Research and Development 19
Centre for Drug Research and Development, Key Employees 20

List of Figures
Centre for Drug Research and Development, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Centre for Drug Research and Development, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Centre for Drug Research and Development, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Centre for Drug Research and Development, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Centre for Drug Research and Development, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Centre for Drug Research and Development, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Centre for Drug Research and Development, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Centre for Drug Research and Development, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Centre for Drug Research and Development, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Centre for Drug Research and Development:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Cellectis SA (ALCLS):企業の財務・戦略的SWOT分析
    Summary Cellectis SA (Cellectis) is a clinical-stage biopharmaceutical company that research, develop and commercialise rational genome engineering technologies. The company pioneers gene editing company, deploying core proprietary technologies to develop off-the-shelf immunotherapies to target and …
  • Singapore Power Ltd:企業の戦略的SWOT分析
    Singapore Power Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • FLSmidth & Co AS (FLS):企業の財務・戦略的SWOT分析
    FLSmidth & Co AS (FLS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Tenaga Nasional Berhad:発電所・企業SWOT分析
    Tenaga Nasional Berhad – Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employ …
  • Monica Healthcare Ltd:医療機器:M&Aディール及び事業提携情報
    Summary Monica Healthcare Ltd (MHL), a subsidiary of GE Healthcare LLC, is a medical device company that develops and commercializes fetal monitoring devices for use during labor and uterine activity applications. The company provides products such as monica AN24 with IF24, monica AN24 with VS progr …
  • Acer Incorporated:企業の戦略・SWOT・財務情報
    Acer Incorporated - Strategy, SWOT and Corporate Finance Report Summary Acer Incorporated - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • EBTEC Corporation:企業の戦略・SWOT・財務情報
    EBTEC Corporation - Strategy, SWOT and Corporate Finance Report Summary EBTEC Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Lexmark International Inc:企業の戦略的SWOT分析
    Lexmark International Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Hague and London Oil PLC:石油・ガス:M&Aディール及び事業提携情報
    Summary Hague and London Oil PLC (HALO), formerly Wessex Exploration plc, is an oil and gas exploration company that develops resource properties. The company acquires, explores, produces, and develops oil and gas resource properties across the UK. Its projects comprise assets in the Philippines, Gu …
  • Marathon Petroleum Corporation (MPC)-石油・ガス分野:企業M&A・提携分析
    Summary Marathon Petroleum Corporation (MPC) is a downstream energy company, which refines, markets and transports petroleum products. It owns and operates refineries in the Gulf Coast and Midwest regions of the US. MPC owns common carrier pipeline systems that transport crude oil and refined produc …
  • The Hong Kong Jockey Club:企業の戦略的SWOT分析
    The Hong Kong Jockey Club - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Eisai Co., Ltd.:企業の戦略・SWOT・財務分析
    Eisai Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Eisai Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Whiting Petroleum Corporation:企業の戦略・SWOT・財務分析
    Whiting Petroleum Corporation - Strategy, SWOT and Corporate Finance Report Summary Whiting Petroleum Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • DP World Ltd:企業の戦略的SWOT分析
    DP World Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Orly International, Inc.:企業の戦略・SWOT・財務分析
    Orly International, Inc. - Strategy, SWOT and Corporate Finance Report Summary Orly International, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Velan Inc (VLN):企業の財務・戦略的SWOT分析
    Velan Inc (VLN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Immunicom Inc-医療機器分野:企業M&A・提携分析
    Summary Immunicom Inc (Immunicom) is a specialty biotechnology company with focus on the development of a blood filtering device for the treatment of cancer and autoimmune diseases. The company’s lead program, sTNFR Immunopheresis, is a non-drug based cancer therapy that uses a proprietary immunoads …
  • NTPC Ltd (NTPC):電力:M&Aディール及び事業提携情報
    Summary NTPC Ltd (NTPC) is a Public sector undertaking energy conglomerate. It has presence in the entire value chain of the power generation business. The company produces electricity and sells that to state power utilities on wholesale basis. NTPC generates power using coal, gas, liquid fuel and h …
  • Subex Ltd (SUBEX):企業の財務・戦略的SWOT分析
    Subex Ltd (SUBEX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Kallpa Generacion SA:企業の発電所・SWOT分析2018
    Kallpa Generacion SA - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employee …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆